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Background: Radial route of access, though low in adoption, is
being increasingly used for coronary angiogram and in-
terventions. Studies consistently demonstrate an increase in ra-
diation exposure with radial access. The aim of study was to
compare radiation exposure by assessing fluoroscopy time and
arterial access route.
Methods: We retrospectively evaluated 469 consecutive patients
in Rajiv Gandhi General Hospital, a tertiary care center, who un-
derwent coronary angiogram or PCI, done by experienced and
trainee postgraduates from April 2014 to June 2014. The fluoros-
copy time, used as a surrogate marker for radiation exposure, was
measured for both diagnostic angiograms and coronary
interventions.
Results: Mean fluoroscopy timing for diagnostic angiogram was
significantly higher with transradial approach (TRA - 7.14 mins vs
TFA 4.93mins) and this difference wasmaintained in experienced
operator subgroup though with reduced mean times for both
radial and femoral access. Mean fluoroscopic timing for r-PCI,
though high, was statistically insignificant compared with f-PCI
(TRAe 16.91mins vs TFAe 16.11mins). Furthermean fluoroscopy
time was lower with experienced operators for both arterial ac-
cess routes.
Conclusion: There was significant increase in fluoroscopy time
with radial access when compared with femoral by more than 40
%, however this difference was not observed during PCI. So there
is a scope for reducing radiation exposure with radial access for
diagnostic angiograms.
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Background: To evaluate the outcome of PCI vs CABG in unpro-
tected left main coronary artery disease (ULMCAD) in respect to
mortality, CVA, re-infarction, stent restenosis and thrombosis and
need for urgent revascularization in 3 tertiary care centers of
eastern India.
Methods: We analyzed 102 consecutive patients with ULMCAD, 52
patients were treated with CABG and 50 patients with PCI with
DES. The selection procedure was not blinded, because PCI is not a
class I indication for ULMCAD. The decision whether to perform
PCI (vs CABG) wasmade when lesion characteristics were suitable
and
 Surgery was contraindicated or very high risk by a panel of
cardiologists and surgeons; or
 The preference for PCI stated by patient after explanation of pros
and cons.
Results: At 30 days follow-up, the rates of mortality, myocardial
infarction, TVR and CVA were similar. At one year follow-up, the
rates of mortality, myocardial infarction, TVR and CVA were
13.4%, 0%, 3.8 %, and 7.6% respectively, in the CABG group and 8%,
0%,4%, and 2% respectively, in the PCI group and they did not
differ significantly.
In the elective sub-group, the CABG arm (vs PCI arm) had similar
rate of in-hospital MACE and one year MACE (P¼ 0.933 at 30 days
and 0.343 at 1 yr). In the emergent group, at 30 days it was showing
a trend towards higher MACE rate in CABG arm (P ¼ 0.093). It
became statistically higher in the CABG arm than PCI at 1-year (P¼
0.440 for one year MACE). The difference in mortality was statis-
tically non-significant both at 30 days and 1 yr.
Conclusions: In this multi-center non-blinded study, no signifi-
cant difference was observed between PCI and CABG for LMCA
disease in the combined incidence of cardiac death, myocardial
infarction, CVA, and TVR. In fact, in the emergency group, PCI had
significantly lower one-year MACE though the sample size was
small. We conclude that PCI on ULMCAD is an alternative option
for patients with high surgical risk and suitable lesion morphol-
ogy.
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Background: We conducted a study comparing iohexol (Omnipa-
que) and Iodixanol (Visipaque) for contrast nephropathy in pa-
tients undergoing percutaneous diagonostic and therapeutic
coronary interventions.
Methods: Total of 194 patients who underwent interventions were
assessed for change in serum creatnine levels from baseline
creatinine, after 24 hours, 48 hours and 72 hours of exposure to
contrast media. Each patient was randomly assigned to receive
one of the two contrast media. The volume used varied and was
not standardized.
Results: The mean serum creatinine (mg/dl) at 72 hours after
contrast exposure in Iodixanol group was (1.1834) compared to
mean baseline serum creatinine (mg/dl) value of (1.0945) and that
in Iohexol group was (1.250) compared to mean baseline value of
(1.0433). This difference of rise in mean serum creatinine at 72
hours of contrast exposure between Iodixanol and iohexol was
statistically significant (P value 0.030). In diabetics we found that
the increase in mean serum creatinine (mg/dl) in Iodixenol group
at 72 hours was 1.1245 from the baseline value of 1.0325 while in
Iohexol group at 72 hours the increase in mean serum creatnine
was 1.3485 from the baseline value of 1.0520. This difference was
statistically significant. The percentage of patients in iodixanol
group who developed contrast induced nephropathy was 2.06%,
none of them was diabetic, whereas in iohexol group, 5.15% pa-
tients developed contrast induced nephropathy, out of them one
was diabetic.
Conclusions: There was a significant increase in serum creatinine
after exposure to contrast agents. The increase in serum creati-
nine was more in patients who received iohexol as compared to
patients who received iodixanol. Thus, the incidence of contrast
induced nephropathy was more in patients who received iohexol
than those who received iodixanol.
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